(Q40721475)

23 September 2017

1 reference

title

Corticosteroid pulse therapy in active rheumatoid arthritis (English)

1 reference

23 September 2017

Weusten BL

1

1 reference

PubMed ID

8122121

23 September 2017

Jacobs JW

series ordinal

2

1 reference

PubMed ID

8122121

23 September 2017

Bijlsma JW

series ordinal

3

1 reference

23 September 2017

1 December 1993

1 reference

Seminars in Arthritis and Rheumatism

23 September 2017

1 reference

23 September 2017

23

1 reference

23 September 2017

3

1 reference

23 September 2017

183-192

1 reference

Reversal of renal allograft rejection with intravenous methylprednisolone “pulse” therapy

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Pulse methylprednisolone therapy in idiopathic, rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

High-dose intravenous methylprednisolone in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Combination therapy with pulsed methylprednisolone in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide, and sodium aurothiomalate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Pulsed methylprednisolone in active early rheumatoid disease: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Sudden death after methylprednisolone pulse therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Fatal Arrhythmia After Pulse Methylprednisolone Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Complications of Steroid Therapy for Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Fatal disseminated aspergillosis in an asthmatic patient treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Hypersensitivity reaction to pulse dose of methylprednisolone (Solumedrol): a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Seizure after pulse therapy with methyl prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Methylprednisolone pulse therapy and peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Gastroscopic evaluation of anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Acute changes in calcium and bone metabolism during methylprednisolone pulse therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

“Pulse” methylprednisolone therapy in the treatment of severe glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2805%2980039-3

7 January 2021

10.1016/S0049-0172(05)80039-3

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8122121